1. Autoantibodies may predict the neurological severity of patients with Wilson disease. (3rd October 2022) Authors: Wolska, M; Eyileten, C; Nowak, A; Palejko, A; Cudna, A; Litwin, T; Antczak-Kowalska, M; Kurkowska-Jastrzebska, I; Czlonkowska, A Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Issue 12 (December 2018) Authors: Kasner, Scott E; Swaminathan, Balakumar; Lavados, Pablo; Sharma, Mukul; Muir, Keith; Veltkamp, Roland; Ameriso, Sebastian F; Endres, Matthias; Lutsep, Helmi; Messé, Steven R; Spence, J David; Nedeltechev, Krassen; Perera, Kanjana; Santo, Gustavo; Olavarria, Veronica; Lindgren, Arne; Bangdiwala, S... Journal: Lancet neurology Issue: Volume 17:Issue 12(2018) Page Start: 1053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Accuracy of visual cervical screening: verification bias revisited. (2nd August 2017) Authors: Wentzensen, N; Litwin, T Journal: BJOG Issue: Volume 125:Number 5(2018) Page Start: 554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗